HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapy for the mucopolysaccharidoses.

Abstract
Better understanding of disease pathophysiology, improved supportive care and availability of disease-specific treatments for some of the mucopolysaccharidosis (MPS) disorders have greatly improved the outlook for patients with MPS disorders. Optimal management of these multisystemic disorders involves a multidisciplinary team and regular, comprehensive follow-up. Enzyme replacement therapy (ERT) is now available for MPS I (Hurler, Hurler-Scheie and Scheie syndromes) (laronidase), MPS II (Hunter syndrome) (idursulfase) and MPS VI Maroteaux-Lamy (galsulfase), and is in development for MPS IV (Morquio syndrome) and MPS VII (Sly syndrome). Benefits of ERT can include improved walking ability, improved respiration and enhanced quality of life. Haematopoietic stem cell transplantation (HSCT) can preserve cognition and prolong survival in very young children with the most severe form of MPS I, and is under investigation for several other MPS disorders. Better tissue matching techniques, improved graft-vs-host prophylaxis and more targeted conditioning regimens have improved morbidity and mortality associated with HSCT.
AuthorsVassili Valayannopoulos, Frits A Wijburg
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 50 Suppl 5 Pg. v49-59 (Dec 2011) ISSN: 1462-0332 [Electronic] England
PMID22210671 (Publication Type: Journal Article, Review)
Chemical References
  • Recombinant Proteins
  • N-Acetylgalactosamine-4-Sulfatase
  • galsulfase
  • Iduronate Sulfatase
  • idursulfase
  • Iduronidase
Topics
  • Clinical Trials as Topic (methods)
  • Enzyme Replacement Therapy (methods)
  • Hematopoietic Stem Cell Transplantation (methods)
  • Humans
  • Iduronate Sulfatase (therapeutic use)
  • Iduronidase (therapeutic use)
  • Mucopolysaccharidoses (complications, therapy)
  • N-Acetylgalactosamine-4-Sulfatase (therapeutic use)
  • Recombinant Proteins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: